Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis

Journal of Neuroimmunology

Volumn 195, Issue 1-2, 2008, Pages 96-99

  Romi, Fredrik R ^a   Gilhus, Nils Erik ^a,b   Luckman, Steven P ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Agrin; MMP 3; Myasthenia gravis

Indexed keywords

STROMELYSIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION;

CHI-SQUARE DISTRIBUTION; HUMANS; MATRIX METALLOPROTEINASE 3; MYASTHENIA GRAVIS;

EID: 42049094893     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.10.018     Document Type: Article

References (18)

1. Borges L.S., and Ferns M. Agrin-induced phosphorylation of the acetylcholine receptor regulates cytoskeletal anchoring and clustering. J. Cell Biol. 153 (2001) 1-11
2. Christensen P.B., Jensen T.S., Tsiropoulos I., Sorensen T., Kjaer M., Hojer-Pedersen E., Rasmussen M.J., and Lehfeldt E. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol. Scand. 91 (1995) 192-195
3. Fuhrer C., Sugiyama J.E., Taylor R.G., and Hall Z.W. Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle. EMBO 16 (1997) 4951-4960
4. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., and Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 (2001) 365-368
5. Jones G., Herczeg A., Ruegg M.A., Lichtsteiner M., Kröger S., and Brenner H.R. Substrate-bound agrin induces expression of acetylcholine receptor epsilon-subunit gene in cultured mammalian muscle cells. PNAS 93 (1996) 5985-5990
6. Kotajima L., Aotsuka S., Fujimani M., Okawa-Tatatsuji M., Kinoshita M., Sumiya M., and Obata K. Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis. Clin. Exp. Rheumatol. 16 (1998) 409-415
7. Li Z., Forester N., and Vincent A. Modulation of acetylcholine receptor function in TE671 (rhabdomyocyosarcoma) cells by non-AchR ligands: possible relevance to seronegative myasthenia gravis. J. Neuroimmunol. 64 (1996) 179-183
8. Lindstrøm J.M., Seybold M.E., Lennon V.A., Whittingham S., and Duane D.D. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975 classical article. Neurology 51 (1998) 933-939
9. McConville J., Farrugia M.E., Beeson D., Kishore U., Metcalfe R., Newsom-Davis J., and Vincent A. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann. Neurol. 55 (2004) 580-584
10. Meier T., Masciulli F., Moore C., Schoumacher F., Eppenberger U., Denzer U., Jones G., and Brenner H.R. Agrin can mediate acetylcholine receptor gene expression by aggregation of muscle-derived neuregulins. J. Cell Biol. 141 (1998) 715-726
11. Mossman S., Vincent A., and Newsom-Davis J. Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1 (1986) 116-119
12. Romi F., Aarli J.A., and Gilhus N.E. Seronegative myasthenia gravis: disease severity and prognosis. Eur. J. Neurol. 12 (2005) 413-418
13. Sternlicht M.D., and Werb Z. ECM proteinases. In: Kreis T., and Vale R. (Eds). Guidebook to the Extracellular Matrix and Adhesion Proteins (1999), Oxford University Press, New York 503-562
14. Sthoeger Z., Neiman A., Elbirt D., Zinger H., Magen E., Burstein R., Eitan S., Abarbanel J., and Mozes E. High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study. Am. J. Med. Sci. 331 (2006) 4-9
15. VanSaun M., and Werle M.J. Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J. Neurobiol. 43 (2000) 140-149
16. Vansaun M., Herrera A.A., and Werle M.J. Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice. J. Neurocytol. 32 (2003) 1129-1142
17. Wilcox N. Myasthenia gravis. Curr. Opin. Immunol. 5 (1993) 910-917
18. Zucker S., Lysik R.M., Zarrabi M.H., Greenwald R.A., Gruber B., Tickle S.P., Baker T.S., and Docherty A.J. Elevated plasma stromelysin levels in arthritis. J. Rheumatol. 21 (1994) 2329-2333